Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
Novel adoptive transfer mouse models in CLL
Elisa ten Hacken
Highlights from ASH 2016: whole-genome sequencing to identify genomic lesions in ALL
The genetics of multiple myeloma and how we can use it to improve outcomes
Are IDH mutations good minimal residual disease (MRD) markers in acute myeloid leukemia (AML)?